Elevance Health (ELV) Accounts Payables (2009 - 2026)

Elevance Health (ELV) has 18 years of Accounts Payables data on file, last reported at $6.6 billion in Q2 2026.

• On a quarterly basis, Accounts Payables fell 8.88% year-over-year to $6.6 billion in Q2 2026; TTM through Jun 2026 was $6.6 billion, a 8.88% decrease from a year earlier, with the FY2025 full-year figure at $7.3 billion, up 5.7% from the prior year.
• Accounts Payables for Q2 2026 stood at $6.6 billion, up from $6.2 billion in the prior quarter.
• Over the last five years, Accounts Payables for ELV reached as high as $7.3 billion in Q4 2025 and fell as low as $4.9 billion in Q1 2023.
• Historically, Accounts Payables has averaged $6.1 billion across 5 years, with a median of $6.0 billion in 2023.
• Across the five-year window, Accounts Payables decreased 16.73% in 2022 and rose 26.35% in 2025, its largest moves.
• Year by year, Accounts Payables stood at $5.6 billion in 2022, then increased by 23.24% to $6.9 billion in 2023, then rose by 0.25% to $6.9 billion in 2024, then grew by 5.7% to $7.3 billion in 2025, then slipped by 9.42% to $6.6 billion in 2026.
• Per Business Quant data, the three most recent Accounts Payables figures were $6.6 billion in Q2 2026, $6.2 billion in Q1 2026, and $7.3 billion in Q4 2025.